4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-031243
EVP, Chief Financial Officer sold 15,310 shares at $22.50 ($344,475)
- EVP, Chief Financial Officer acquired 29,738 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-17 | Option exercise | +14,869 | 22,346 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-17 | Option exercise | +14,869 | 37,215 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-17 | Sale | −15,310 | $22.50 | $344,475 | 21,905 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-17 | Option exercise · Restricted Stock Units | −14,869 | 24,782 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-05-17 | Option exercise · Restricted Stock Units | −14,869 | 24,782 | D | ||
| Open-market sales · 15,310 sh · avg $22.50 · $344,475 | |||||||
Loading xslF345X04/doc4.xml…